7.16
Üç Kompartımanlı Açık Model
Üç kompartımanlı açık model, ilaçların ekstravasküler uygulamadan sonra dağılımını ve atılımını tanımlamak için kullanılan bir farmakokinetik modeldir…
Üç bölmeli modeller, iki bölmeli modele benzer ancak ek bir derin doku bölmesine sahiptir.
Derin doku bölmesi, kemik veya yağ gibi zayıf perfüze edilmiş dokuları veya sıkıca dokuya bağlı ilaçları temsil eder.
Bu modeli gerektiren ilaçlar merkeze hızlı bir şekilde, dokuya daha az hızlı ve derin doku bölmesine çok yavaş bir şekilde dağılır.
Bu denklem, ilacın merkezi bölmeye giren ve çıkan akış hızını temsil eder.
α, β ve γ üsleri, sırasıyla merkezi, periferik ve derin doku bölmeleri için birinci dereceden hız sabitlerini gösterir.
İstatistiksel olarak, üç bölmeli bir denklem, üç üstel yapısını yansıtmak için λ1, λ2 ve λ3 kullanılarak da temsil edilebilir.
Kalıntı yöntemi kullanılarak, gösterilen formüller kullanılarak çeşitli farmakokinetik parametreler hesaplanabilir.
Bu modeller, çeşitli bölmelerde ilaç dağılımını tahmin etmeye ve dozaj rejimlerini optimize etmeye yardımcı olur.
View the full transcript and gain access to JoVE Core videos
Q1: What are the three compartments in a three-compartment pharmacokinetic model?
A three-compartment model includes a central compartment representing plasma, a highly perfused peripheral compartment representing organs like the liver and kidneys, and a scarcely perfused peripheral compartment representing adipose tissue and certain muscle groups. This structure allows the model to describe drug distribution across tissues with varying blood supply.
Q2: How does the deep tissue compartment differ from other compartments in drug distribution?
The deep tissue compartment represents poorly perfused tissues like bone or fat where drugs distribute very slowly. Unlike the central compartment, which receives rapid drug distribution, and the peripheral compartment, which receives moderate distribution, the deep tissue compartment is necessary for drugs that are tightly tissue-bound or accumulate in these poorly perfused areas.
Q3: What do the rate constants α, β, and γ represent in three-compartment models?
The exponents α, β, and γ denote first-order rate constants for the central, peripheral, and deep tissue compartments, respectively. These constants describe the rate of drug transfer between compartments and elimination from the central compartment, enabling calculation of key pharmacokinetic parameters through mathematical modeling and regression analysis.
Q4: Why is a three-compartment model used instead of a simpler two-compartment model?
A three-compartment model is necessary when drugs distribute to poorly perfused tissues or become tightly tissue-bound, requiring representation of a deep tissue compartment. This additional compartment provides more accurate predictions of drug distribution and elimination kinetics, enabling better optimization of dosage regimens for drugs with complex tissue distribution patterns.
Q5: How is the plasma concentration of a drug described mathematically in three-compartment models?
Plasma concentration in three-compartment models is described by a multi-exponential equation involving three exponents corresponding to the rate of drug transfer between compartments. This triexponential nature can be represented using λ1, λ2, and λ3, with each term reflecting the contribution of different compartments to overall drug concentration over time.
Q6: What is the method of residuals and how is it applied in three-compartment analysis?
The method of residuals is a mathematical technique used to calculate various pharmacokinetic parameters from three-compartment models using specific formulae. This approach helps isolate and quantify the contribution of each compartment to drug elimination and distribution, providing insights into elimination rate constants and enabling accurate prediction of drug concentrations over time.
Q7: How do three-compartment models help optimize drug dosage regimens?
Three-compartment models predict drug distribution across central, peripheral, and deep tissue compartments, revealing how drugs accumulate or eliminate from different tissues. By understanding these distribution patterns and calculating elimination rate constants through regression analysis, clinicians can optimize dosing intervals and amounts to maintain therapeutic concentrations while ensuring patient safety.